Andra AP fonden Boosts Holdings in Cardinal Health, Inc. $CAH

Andra AP fonden lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 169.0% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 30,393 shares of the company’s stock after acquiring an additional 19,093 shares during the quarter. Andra AP fonden’s holdings in Cardinal Health were worth $6,422,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Florida Financial Advisors LLC grew its stake in shares of Cardinal Health by 21.0% during the first quarter. Florida Financial Advisors LLC now owns 15,203 shares of the company’s stock valued at $3,213,000 after buying an additional 2,643 shares during the last quarter. Parallel Advisors LLC lifted its position in Cardinal Health by 9.0% in the first quarter. Parallel Advisors LLC now owns 2,968 shares of the company’s stock valued at $627,000 after purchasing an additional 244 shares during the last quarter. AlphaCentric Advisors LLC boosted its stake in shares of Cardinal Health by 43.6% during the first quarter. AlphaCentric Advisors LLC now owns 1,865 shares of the company’s stock valued at $394,000 after purchasing an additional 566 shares during the period. SEB Asset Management AB bought a new position in shares of Cardinal Health in the first quarter worth approximately $16,483,000. Finally, Swiss National Bank grew its holdings in shares of Cardinal Health by 7.2% in the first quarter. Swiss National Bank now owns 697,300 shares of the company’s stock worth $147,346,000 after purchasing an additional 46,900 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 2.6%

CAH opened at $221.09 on Thursday. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21. The stock has a market cap of $51.78 billion, a PE ratio of 33.81, a PEG ratio of 1.11 and a beta of 0.49. The business has a 50 day moving average of $218.69 and a 200-day moving average of $214.20.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the prior year, the company earned $2.35 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 10.77 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.50%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on CAH shares. William Blair began coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating for the company. Bank of America upped their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. UBS Group increased their target price on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a report on Monday. Citigroup restated a “buy” rating on shares of Cardinal Health in a report on Thursday, July 2nd. Finally, Wells Fargo & Company lowered their price target on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $250.07.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.